SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-046528
Filing Date
2022-08-11
Accepted
2022-08-10 20:12:34
Documents
15
Period of Report
2022-08-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164185-8k_inmedphar.htm   iXBRL 8-K 29913
2 PRESS RELEASE, DATED AUGUST 9, 2022 ea164185ex99-1_inmedphar.htm EX-99.1 10902
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5094
  Complete submission text file 0001213900-22-046528.txt   265521

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20220810.xsd EX-101.SCH 3202
5 XBRL DEFINITION FILE inm-20220810_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20220810_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20220810_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea164185-8k_inmedphar_htm.xml XML 4179
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221153293
SIC: 2834 Pharmaceutical Preparations